Megan E Laurance

Title: Megan E Laurance: Innovator in Diabetes Treatment

Introduction

Megan E Laurance is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of diabetes treatment through her innovative research and development of insulin-secreting beta-cell lines. With a total of 3 patents to her name, her work is paving the way for advancements in diabetes management.

Latest Patents

Megan's latest patents include groundbreaking developments in glucose-responsive insulin-secreting beta-cell lines. One of her notable inventions describes a line of beta cells capable of maintaining high levels of insulin secretion in culture. These cells are particularly useful in treating diabetes, as they can be encapsulated in an insulin-permeable membrane device and implanted into patients. Another patent focuses on a cell culture of correctly regulated beta-cells that exhibit enhanced insulin secretion. This patent also outlines a method for selecting these correctly regulated beta-cells, ensuring their effectiveness in therapeutic applications.

Career Highlights

Throughout her career, Megan has worked with notable organizations such as Cytotherapeutics, Inc. and Brown University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in diabetes research.

Collaborations

Megan has collaborated with esteemed colleagues, including David Knaack and Deborah M Fiore. These partnerships have further enriched her research and have been instrumental in the development of her innovative patents.

Conclusion

Megan E Laurance is a trailblazer in the field of diabetes treatment, with her innovative patents and collaborations driving progress in this critical area of healthcare. Her work continues to inspire advancements that may significantly improve the lives of diabetes patients.